Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020

WHAT IS ALREADY KNOWN ON THIS TOPIC? Chronic obstructive pulmonary disease (COPD) exacerbations increase household economic burden, but there is limited evidence from prospective cohort studies in China about the impact of vaccination on economic burden. WHAT IS ADDED BY THIS REPORT? This study demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhang, Pingshu, An, Zhijie, Ma, Ying, Wang, Yamin, Wang, Liye, Liu, Yunqiu, Yuan, Xiaodong, Li, Keli, Yin, Zundong, Wang, Huaqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236643/
https://www.ncbi.nlm.nih.gov/pubmed/37274769
http://dx.doi.org/10.46234/ccdcw2023.086
_version_ 1785052982953377792
author Li, Yan
Zhang, Pingshu
An, Zhijie
Ma, Ying
Wang, Yamin
Wang, Liye
Liu, Yunqiu
Yuan, Xiaodong
Li, Keli
Yin, Zundong
Wang, Huaqing
author_facet Li, Yan
Zhang, Pingshu
An, Zhijie
Ma, Ying
Wang, Yamin
Wang, Liye
Liu, Yunqiu
Yuan, Xiaodong
Li, Keli
Yin, Zundong
Wang, Huaqing
author_sort Li, Yan
collection PubMed
description WHAT IS ALREADY KNOWN ON THIS TOPIC? Chronic obstructive pulmonary disease (COPD) exacerbations increase household economic burden, but there is limited evidence from prospective cohort studies in China about the impact of vaccination on economic burden. WHAT IS ADDED BY THIS REPORT? This study demonstrated the economic burden of COPD exacerbations, pneumonia, and hospitalization in COPD patients in China is substantial. Influenza vaccine and 23-valent pneumococcal polysaccharide vaccine (PPSV23), separately or together, were significantly associated with decreased economic burden. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Our study supports evidence on recommendations that COPD patients in China are offered both influenza vaccine and PPSV23.
format Online
Article
Text
id pubmed-10236643
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-102366432023-06-03 Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020 Li, Yan Zhang, Pingshu An, Zhijie Ma, Ying Wang, Yamin Wang, Liye Liu, Yunqiu Yuan, Xiaodong Li, Keli Yin, Zundong Wang, Huaqing China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ON THIS TOPIC? Chronic obstructive pulmonary disease (COPD) exacerbations increase household economic burden, but there is limited evidence from prospective cohort studies in China about the impact of vaccination on economic burden. WHAT IS ADDED BY THIS REPORT? This study demonstrated the economic burden of COPD exacerbations, pneumonia, and hospitalization in COPD patients in China is substantial. Influenza vaccine and 23-valent pneumococcal polysaccharide vaccine (PPSV23), separately or together, were significantly associated with decreased economic burden. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Our study supports evidence on recommendations that COPD patients in China are offered both influenza vaccine and PPSV23. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023-05-19 /pmc/articles/PMC10236643/ /pubmed/37274769 http://dx.doi.org/10.46234/ccdcw2023.086 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Li, Yan
Zhang, Pingshu
An, Zhijie
Ma, Ying
Wang, Yamin
Wang, Liye
Liu, Yunqiu
Yuan, Xiaodong
Li, Keli
Yin, Zundong
Wang, Huaqing
Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
title Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
title_full Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
title_fullStr Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
title_full_unstemmed Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
title_short Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
title_sort impact of influenza and pneumococcal polysaccharide vaccination on economic burden from acute exacerbations of chronic obstructive pulmonary disease — hebei province, china, november 2018 to november 2020
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236643/
https://www.ncbi.nlm.nih.gov/pubmed/37274769
http://dx.doi.org/10.46234/ccdcw2023.086
work_keys_str_mv AT liyan impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT zhangpingshu impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT anzhijie impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT maying impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT wangyamin impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT wangliye impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT liuyunqiu impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT yuanxiaodong impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT likeli impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT yinzundong impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020
AT wanghuaqing impactofinfluenzaandpneumococcalpolysaccharidevaccinationoneconomicburdenfromacuteexacerbationsofchronicobstructivepulmonarydiseasehebeiprovincechinanovember2018tonovember2020

Ejemplares similares